ID

30942

Descrição

Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse; ODM derived from: https://clinicaltrials.gov/show/NCT00753792

Link

https://clinicaltrials.gov/show/NCT00753792

Palavras-chave

Versões (1)
  1. 05/07/2018 05/07/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

5 de julho de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Multiple Sclerosis NCT00753792

Inglês

Eligibility Multiple Sclerosis NCT00753792

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. to have been diagnosed ms remittent recurrent according to mc donald 20052 criteria.
Descrição

Multiple Sclerosis, Relapsing-Remitting

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0751967
2. to have an edss between 0 and 5 before the relapse.
Descrição

EDSS | Status pre- Relapse

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0451246
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C0035020
3. the symptoms have begun after at least one month of previous stability.
Descrição

Symptom Onset Post Stability Previous

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4086878
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0205156
4. the symptoms have started maximum 15 days before the inclusion.
Descrição

Symptom Onset Recently

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4086878
UMLS CUI [1,2]
C0332185
5. the patient is capable of having an adequate communication with the investigator and to carry out with the clinical trial requisites.
Descrição

Able to communicate Investigator | Protocol Compliance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2364293
UMLS CUI [1,2]
C0035173
UMLS CUI [2]
C0525058
6. to be or not to be with allowed immunomodulatory therapy (ifn-b /ag).
Descrição

Immunomodulation Interferon-beta | Absence Immunomodulation Interferon-beta

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1963758
UMLS CUI [1,2]
C0015980
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1963758
UMLS CUI [2,3]
C0015980
7. to be capable and to be willing to ingest the medication.
Descrição

Ingestion Pharmaceutical Preparations Able | Ingestion Pharmaceutical Preparations Willing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0232478
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0232478
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0600109
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. first inflammatory neurological episode (relapse).
Descrição

First episode Neurologic inflammatory | Relapse

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0439615
UMLS CUI [1,2]
C0205494
UMLS CUI [1,3]
C0333348
UMLS CUI [2]
C0035020
2. multiple sclerosis secondary progressive or primary progressive.
Descrição

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0751965
UMLS CUI [2]
C0751964
3. the symptoms have gone on for less than 24 hours.
Descrição

Symptoms Duration

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0449238
4. to be in treatment or have been treated with corticoids during the three months before.
Descrição

Adrenal Cortex Hormones

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001617
5. patients in treatment with immunosuppressors (azathioprine, mitoxantrone, ciclofosfamide...)
Descrição

Immunosuppressive Agents | Azathioprine | Mitoxantrone | Cyclophosphamide

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0004482
UMLS CUI [3]
C0026259
UMLS CUI [4]
C0010583
6. pregnancy or breastfeeding or women in fertile age who don't use contraceptives measurements.
Descrição

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Lacking

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0332268
7. illnesses with contraindication treatment with corticoids.
Descrição

Illness | Medical contraindication Adrenal Cortex Hormones

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0221423
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0001617
8. antecedents of serious adverse effects or hypersensitive to related study medication.
Descrição

Adverse effects Serious Investigational New Drugs Related | Hypersensitivity Investigational New Drugs Related

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0879626
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0013230
UMLS CUI [1,4]
C0439849
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C0439849
9. patients who wouldn´t be able to perform periodic rmn explorations, patients who are not collaborative or who need anesthesia.
Descrição

MRI Periodic Unable | Patient uncooperative | Patient need for Anesthesia

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C0332182
UMLS CUI [1,3]
C1299582
UMLS CUI [2]
C0747308
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C0002903
10. patients with intolerance to lactose.
Descrição

Lactose Intolerance

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0022951
11. patients with allergy to contrast used in rmn.
Descrição

Contrast media allergy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0570562
12. patients with chronic kidney disease.
Descrição

Chronic Kidney Diseases

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1561643
13. patients in treatment with natalizumab.
Descrição

natalizumab

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1172734
Voltar ao início da página

Similar models

Eligibility Multiple Sclerosis NCT00753792

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Relapsing-Remitting
Item
1. to have been diagnosed ms remittent recurrent according to mc donald 20052 criteria.
boolean
C0751967 (UMLS CUI [1])
EDSS | Status pre- Relapse
Item
2. to have an edss between 0 and 5 before the relapse.
boolean
C0451246 (UMLS CUI [1])
C0332152 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
Symptom Onset Post Stability Previous
Item
3. the symptoms have begun after at least one month of previous stability.
boolean
C4086878 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,4])
Symptom Onset Recently
Item
4. the symptoms have started maximum 15 days before the inclusion.
boolean
C4086878 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Able to communicate Investigator | Protocol Compliance
Item
5. the patient is capable of having an adequate communication with the investigator and to carry out with the clinical trial requisites.
boolean
C2364293 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
Immunomodulation Interferon-beta | Absence Immunomodulation Interferon-beta
Item
6. to be or not to be with allowed immunomodulatory therapy (ifn-b /ag).
boolean
C1963758 (UMLS CUI [1,1])
C0015980 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C1963758 (UMLS CUI [2,2])
C0015980 (UMLS CUI [2,3])
Ingestion Pharmaceutical Preparations Able | Ingestion Pharmaceutical Preparations Willing
Item
7. to be capable and to be willing to ingest the medication.
boolean
C0232478 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0232478 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
First episode Neurologic inflammatory | Relapse
Item
1. first inflammatory neurological episode (relapse).
boolean
C0439615 (UMLS CUI [1,1])
C0205494 (UMLS CUI [1,2])
C0333348 (UMLS CUI [1,3])
C0035020 (UMLS CUI [2])
Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
Item
2. multiple sclerosis secondary progressive or primary progressive.
boolean
C0751965 (UMLS CUI [1])
C0751964 (UMLS CUI [2])
Symptoms Duration
Item
3. the symptoms have gone on for less than 24 hours.
boolean
C1457887 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Adrenal Cortex Hormones
Item
4. to be in treatment or have been treated with corticoids during the three months before.
boolean
C0001617 (UMLS CUI [1])
Immunosuppressive Agents | Azathioprine | Mitoxantrone | Cyclophosphamide
Item
5. patients in treatment with immunosuppressors (azathioprine, mitoxantrone, ciclofosfamide...)
boolean
C0021081 (UMLS CUI [1])
C0004482 (UMLS CUI [2])
C0026259 (UMLS CUI [3])
C0010583 (UMLS CUI [4])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Lacking
Item
6. pregnancy or breastfeeding or women in fertile age who don't use contraceptives measurements.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0332268 (UMLS CUI [3,3])
Illness | Medical contraindication Adrenal Cortex Hormones
Item
7. illnesses with contraindication treatment with corticoids.
boolean
C0221423 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
Adverse effects Serious Investigational New Drugs Related | Hypersensitivity Investigational New Drugs Related
Item
8. antecedents of serious adverse effects or hypersensitive to related study medication.
boolean
C0879626 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,4])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
MRI Periodic Unable | Patient uncooperative | Patient need for Anesthesia
Item
9. patients who wouldn´t be able to perform periodic rmn explorations, patients who are not collaborative or who need anesthesia.
boolean
C0024485 (UMLS CUI [1,1])
C0332182 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0747308 (UMLS CUI [2])
C0686904 (UMLS CUI [3,1])
C0002903 (UMLS CUI [3,2])
Lactose Intolerance
Item
10. patients with intolerance to lactose.
boolean
C0022951 (UMLS CUI [1])
Contrast media allergy
Item
11. patients with allergy to contrast used in rmn.
boolean
C0570562 (UMLS CUI [1])
Chronic Kidney Diseases
Item
12. patients with chronic kidney disease.
boolean
C1561643 (UMLS CUI [1])
natalizumab
Item
13. patients in treatment with natalizumab.
boolean
C1172734 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial